During the past decade, AdventHealth Hematology and Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Hematology and Oncology" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AdventHealth Hematology and Oncology" are "Advanced Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Small Cell Lung" (1 trials), "Melanoma" (1 trials) and "Metastatic Solid Tumors" (1 trials). Many other conditions were trialed in "AdventHealth Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "AdventHealth Hematology and Oncology" are "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (2 trials), "Encorafenib" (2 trials), "Axitinib" (1 trials), "Cisplatin/carboplatin plus etoposide" (1 trials) and "PF-06939999 dose escalation" (1 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Hematology and Oncology" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AdventHealth Hematology and Oncology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AdventHealth Hematology and Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Hematology and Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".